Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report

CDK12 (Cyclin-Dependent Kinase 12)-mutated prostate cancer patients often respond badly to current therapies. Immunotherapy and platinum-based chemotherapy are recommended based on the molecular features of CDK12-mutated tumors, but the reported patient outcomes are still unsatisfying. Here we repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Sha, Bao, Yige, Zheng, Linmao, Zhao, Jinge, Chen, Yuntian, Huang, Rui, Sun, Guangxi, Zhao, Fengnian, Zhang, Xingming, Liang, Jiayu, Chen, Junru, Wang, Zhipeng, Ni, Yuchao, Chen, Ni, Shen, Pengfei, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447454/
https://www.ncbi.nlm.nih.gov/pubmed/36082136
http://dx.doi.org/10.2147/OTT.S377638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447454/
https://www.ncbi.nlm.nih.gov/pubmed/36082136
http://dx.doi.org/10.2147/OTT.S377638

Ejemplares similares